AI Tool Comparison
OpenEvidence vs Gemini
An objective side-by-side comparison based on global rankings, AI scores, and monthly user data.
Higher Ranked
OpenEvidence
Research & SearchAI clinical evidence search engine that helps physicians find answers from medical literature.
AI Score27.1 / 100
#610
Global Rank
–
Monthly Users
VS
Higher Ranked
Gemini
Writing & ChatGoogle's multimodal AI assistant for text, images, code, and data analysis.
AI Score70.9 / 100
#167
Global Rank
350M+
Monthly Users
Side-by-Side Comparison
| OpenEvidence | Gemini | |
|---|---|---|
| Category | Research & Search | Writing & Chat |
| Global Rank | #610 | #167 |
| AI Score | 27.1/100 | 70.9/100 |
| Monthly Users | – | 350M+ |
| Pricing | Free | Freemium |
| Website | openevidence.com | gemini.google.com |
Pros & Cons
OpenEvidence
- Genuinely free for verified US healthcare professionals, funded entirely by advertising
- Massive real-world adoption — approximately 20 million clinical consultations/month as of January 2026
- Substantial recent funding ($250M Series D, $12B valuation) suggests continued platform investment
- Access requires a US NPI number, excluding non-US healthcare professionals
- Withdrew from the EU and UK entirely in April 2026, cutting off previous international access
- Ad-supported model means pharmaceutical advertising is shown during use
Gemini
- Deeply integrated across Google’s broader ecosystem (Search, Workspace, Android)
- Ultra tier pricing was reduced from its original $250/month, improving accessibility
- API pricing offers genuinely low-cost options (Flash-Lite at $0.10/million tokens) for cost-sensitive applications
- Full Workspace integration requires at least Business Standard ($14/user/month), not available on cheaper Workspace tiers
- Credit-based system layered on top of tier usage limits adds complexity to understanding real usage capacity
- Ultra tier’s $99.99-$199.99/month range represents significant cost for maximum usage limits and Deep Think access